Vidal Perez‐Valero

Author

Vidal Perez‐Valero

Also Known As

V PEREZVALERO, V Pérez-Valero, V Pérez‐Valero, V. Perez-Valero, V. Pérez-Valero, V. Pérez‐Valero, Vidal Perez-Valero, Vidal Perez‐Valero, Vidal Pérez-Valero

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Universidad de Granada Hospital Regional Universitario de Málaga Instituto de Salud Carlos III Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Instituto de Investigación Biomédica de Málaga

About

Vidal Perez‐Valero is an author at Universidad de Granada specializing in nutrition, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	420
2	Health Sciences	8	8	421
3	Public Health	8	8	301
4	Education	1	1	17
5	Engineering	1	1	17

Vidal Perez‐Valero

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Hypovitaminosis D and incidence of obesity: a prospective study Inmaculada González-Molero, Gemma Rojo‐Martínez, Sonsoles Morcillo, European Journal of Clinical Nutrition ObesityMetabolic SyndromeMetabolic DisorderClinical EpidemiologyClinical Nutrition	2013	120
Vitamin D deficiency in Spain: a population-based cohort study Inmaculada González-Molero, Sonsoles Morcillo, Sergio Valdés, European Journal of Clinical Nutrition NutritionNutritional RequirementPublic Health NutritionNutritional ScienceVitamin D Deficiency	2010	108
Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus Miguel Navarro‐Alarcón, H. López-G de la Serrana, Vidal Perez‐Valero, The Science of The Total Environment Metabolic SyndromeNutritionUrine Selenium ConcentrationsBody CompositionBody Status	1999	103
Reduction of body weight, liver steatosis and expression of stearoyl‐CoA desaturase 1 by the isoflavone daidzein in diet‐induced obesity Ana Crespillo, M. Carmen Alonso, Margarita Vida, British Journal of Pharmacology	2011	97
The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats Antonia Serrano, Ignacio del Arco, Francisco Javier Pavón, Neuropharmacology Cannabis UseZucker RatsPsychoactive DrugHealth SciencesFunctional Selectivity	2007	80
Population-Based National Prevalence of Thyroid Dysfunction in Spain and Associated Factors: Di@bet.es Study Sergio Valdés, Cristina Maldonado‐Araque, Ana Lago‐Sampedro, Thyroid	2016	77
Serum Zinc and Copper Concentrations and Cu/Zn ratios in Patients with Hepatopathies or Diabetes C. Terrés-Martos, Miguel Navarro‐Alarcón, F. Martı́n-Lagos, Journal of Trace Elements in Medicine and Biology Metabolic SyndromeHepatologyBioactive MetalLiver PhysiologyDiabetes	1998	60
Anti‐obesity efficacy of LH‐21, a cannabinoid CB<sub>1</sub> receptor antagonist with poor brain penetration, in diet‐induced obese rats Mónica Alonso, Antonia Serrano, Margarita Vida, British Journal of Pharmacology	2011	57
<scp>FNDC</scp>5 could be regulated by leptin in adipose tissue Carolina Gutiérrez‐Repiso, Sara García‐Serrano, Francisca Rodríguez‐Pacheco, European Journal of Clinical Investigation	2014	54
Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study Sergio Valdés, Cristina Maldonado‐Araque, Ana Lago‐Sampedro, Obesity	2017	47

Page 1